MARKET

NAD

NAD

Nuveen Quality Muni Income Fund
NYSE
10.94
-0.05
-0.46%
After Hours: 11.02 +0.08 +0.73% 18:01 11/30 EST
OPEN
10.95
PREV CLOSE
10.99
HIGH
10.96
LOW
10.89
VOLUME
1.19M
TURNOVER
0
52 WEEK HIGH
12.15
52 WEEK LOW
9.51
TOTAL ASSET
2.99B
YTD YIELD
3.50%
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at NAD last week (1120-1124)?
Weekly Report · 3d ago
NAD: Quality Municipal Bond CEF With High Leverage Usage
Nuveen quality muni income fund is a high-level leverage fund within nuveen's national investment-grade municipal bond cefs. Nad aims to provide current income exempt from federal income tax and invest in undervalued municipal securities. Nad recently increased its monthly payout from $.38 to $.44. The fund has a leverage ratio of over 42% and is a buy.
Seeking Alpha · 11/23 14:00
Weekly Report: what happened at NAD last week (1113-1117)?
Weekly Report · 11/20 09:26
VTEB: A Good Muni Proxy
The vanguard tax-exempt bond etf focuses on municipal bonds and offers stability, income generation, and tax benefits. Vteb has a strong focus on investment-grade bonds, providing a relatively low credit risk. The fund offers a diversified portfolio of over 8,300 municipal bonds.
Seeking Alpha · 11/20 07:20
Nuveen Quality Municipal Income Fund goes ex-dividend tomorrow
Nuveen quality muni income fund goes ex-dividend tomorrow nov. 13. $0.044/share monthly dividend is due on dec. 1; for shareholders of record nov. 15; ex-div is nov. 14. Nuveen quality municipal income fund declares $1.00/share quarterly dividend.
Seeking Alpha · 11/13 17:18
Weekly Report: what happened at NAD last week (1106-1110)?
Weekly Report · 11/13 09:25
Weekly Report: what happened at NAD last week (1030-1103)?
Weekly Report · 11/06 09:25
Weekly Report: what happened at NAD last week (1023-1027)?
Weekly Report · 10/30 09:29
More
Profile
Fund Name
Nuveen Quality Muni Income Fund
Inception Date
1999-05-26
Benchmark
S&P Municipal Bond High Yield TR
Advisor Company
Nuveen Fund Advisors LLC
Custodian
State Street Bank and Trust Co
Manager
Stephen Candido, Christopher Drahn, Michael Hamilton